Source: Metallomics. Unidade: IQSC
ABNT
CAMARGO, Mariana Santoro de et al. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity. Metallomics, v. 8, n. 2, p. 179-192, 2016Tradução . . Disponível em: https://doi.org/10.1039/c5mt00227c. Acesso em: 05 out. 2024.APA
Camargo, M. S. de, Silva, M. M. da, Correa, R. S., Vieira, S. D., Castelli, S., D'Anessa, I., et al. (2016). Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity. Metallomics, 8( 2), 179-192. doi:10.1039/c5mt00227cNLM
Camargo MS de, Silva MM da, Correa RS, Vieira SD, Castelli S, D'Anessa I, De Grandis R, Varanda E, Deflon VM, Desideri A, Batista AA. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity [Internet]. Metallomics. 2016 ; 8( 2): 179-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.1039/c5mt00227cVancouver
Camargo MS de, Silva MM da, Correa RS, Vieira SD, Castelli S, D'Anessa I, De Grandis R, Varanda E, Deflon VM, Desideri A, Batista AA. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity [Internet]. Metallomics. 2016 ; 8( 2): 179-192.[citado 2024 out. 05 ] Available from: https://doi.org/10.1039/c5mt00227c